economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

adults

AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis

creativebharatgroup@gmail.com January 13, 2025
PRESS RELEASE – For UK consumer health, medical and trade media only  Risankizumab...
Read More Read more about AbbVie’s SKYRIZI[®] (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis
Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD

Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD

creativebharatgroup@gmail.com January 9, 2025
H. Lundbeck A/S (Lundbeck) announces that the U.S. Food and Drug Administration...
Read More Read more about Lundbeck announces FDA plans to host an Advisory Committee meeting on the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD